Dashboard
Manage Tickers

BCYP


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

55-biggest-movers-from-friday
55 Biggest Movers From Friday
10/25/2021 09:28:32

Gainers

big-cypress-acquisition-corp-stockholders-approve-business-combination-with-sab-biotherapeutics
Big Cypress Acquisition Corp. Stockholders...
10/21/2021 11:21:03

october-spac-merger-calendar-a-look-at-upcoming-votes-stocks-to-watch
October SPAC Merger Calendar: A Look At Up...
10/04/2021 16:13:29

The month of October marks a slowdown in SPAC merger deal votes, but the calendar does include several multibillion-dollar deal...

northland-capital-markets-initiates-coverage-on-big-cypress-acquisition-with-outperform-rating-announces-price-target-of-18
Northland Capital Markets Initiates Covera...
10/04/2021 14:24:53

Northland Capital Markets analyst Tim Chiang initiates coverage on Big Cypress Acquisition (NASDAQ:BCYP) with a Outperform r...

big-cypress-acquisition-merger-partner-sab-biotherapeutics-announces-first-patient-dosed-in-phase-3-nih-activ-2-trial-evaluating-sab-185-for-treatment-of-covid-19
Big Cypress Acquisition Merger Partner SAB...
10/04/2021 11:03:35

SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifi...

benzingas-top-ratings-upgrades-downgrades-for-october-1-2021
Benzinga's Top Ratings Upgrades, Downgrade...
10/01/2021 14:02:57

 

ladenburg-thalmann-initiates-coverage-on-big-cypress-acquisition-with-buy-rating-announces-price-target-of-165
Ladenburg Thalmann Initiates Coverage On B...
10/01/2021 11:01:33

Ladenburg Thalmann analyst Jeffrey Cohen initiates coverage on Big Cypress Acquisition (NASDAQ:BCYP) with a Buy rating and a...

big-cypress-acquisition-corp-merger-partner-sab-biotherapeutics-announces-independent-data-safety-monitoring-board-has-completed-interim-analysis-of-sab-185-in-phase-2-portion-of-activ-2-trial-and-recommended-advancement-to-phase-3
Big Cypress Acquisition Corp. Merger Partn...
09/24/2021 11:02:55

sab-biotherapeutics-awarded-additional-605m-from-barda-and-us-department-of-defense-for-rapid-response-capability-and-advancing-sab-185-for-treatment-of-covid-19
SAB Biotherapeutics Awarded Additional $60...
09/22/2021 11:02:30

  $200 million total awarded to date for DiversitAb™ Rapid Response Antibody Program including Stage 4 COVID-19 Pandemic Respo...

big-cypress-acquisition-merger-partner-sab-biotherapeutics-announces-completion-of-enrollment-in-phase-2a-challenge-trial-of-sab-176-for-the-treatment-of-seasonal-influenza
Big Cypress Acquisition Merger Partner SAB...
09/15/2021 11:01:19

big-cypress-acquisition-corp-spac-merger-partner-sab-biotherapeutics-gives-non-clinical-data-showing-sab-185-potently-neutralizes-deal-lambda-sars-cov-2-variants
Big Cypress Acquisition Corp. SPAC Merger ...
08/11/2021 11:17:15

correction-big-cypress-spac-merger-partner-sab-issued-preclinical-data-on-its-sab-185-this-morning-at-706-am-edt
CORRECTION: Big Cypress SPAC Merger Partne...
07/08/2021 21:16:51

big-cypress-acquisition-corp-spac-merger-partner-sab-biotherapeutics-highlights-publication-of-preclinical-data-showing-sab-185-effectively-neutralizes-sars-cov-2-variants
Big Cypress Acquisition Corp. SPAC Merger ...
07/08/2021 21:14:07

SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifi...

big-cypress-acquisition-corp-spac-merger-partner-sab-biotherapeutics-highlights-publication-of-preclinical-data-demonstrating-sab-185-effectively-neutralizes-sars-cov-2-variants
Big Cypress Acquisition Corp. SPAC Merger ...
07/08/2021 11:08:38

Findings Published in Human Vaccines & Immunotherapeutics Show SAB-185 Neutralizes Virus Strains Containing Substitutions P...

big-cypress-acquisition-corp-announces-confidential-submission-of-s-4-registration-statement-related-to-proposed-business-combination-with-sab-biotherapeutics
Big Cypress Acquisition Corp. Announces Co...
07/07/2021 11:05:25

big-cypress-acquisition-merger-partner-sab-biotherapeutics-reports-dosing-of-first-patient-in-phase-2a-trial-of-sab-176-for-treatment-of-flu
Big Cypress Acquisition Merger Partner, SA...
07/02/2021 11:49:28

sab-biotherapeutics-doses-first-participant-in-phase-2a-trial-of-sab-176-for-the-treatment-of-influenza
SAB Biotherapeutics Doses First Participan...
06/29/2021 11:15:32

SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifi...

sab-biotherapeutics-to-go-public-through-merger-with-big-cypress-acquisition-corp-transaction-implies-enterprise-value-of-325m
SAB Biotherapeutics To Go Public Through M...
06/22/2021 10:03:19

SAB Biotherapeutics (SAB) has entered into a definitive merger agreement with Big Cypress Acquisition Corp. (NASDAQ:BCYP) and...

Core News & Articles
Stocks Making New 52-Week Highs/Lows For W...
02/10/2021 19:30:53

52-Week Highs: BeiGene (BGNE) Plus Therapeutics (PSTV) Bilibili (BILI) Whiting Petroleum (WLL) Yiren Digital (YRD) Cara...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION